First description of CTX-M β-lactamase-producing clinical Escherichia coli isolates from Egypt

被引:52
作者
Al-Agamy, Mohamed Hamed Mohamed
Ashour, Mohamed Seif El-Din
Wiegand, Irith
机构
[1] Univ Bonn, Inst Physiol 1, D-53115 Bonn, Germany
[2] Al Azhar Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt
关键词
Egypt; Escherichia coli; beta-lactamase; CTX-M; multiresistance;
D O I
10.1016/j.ijantimicag.2006.01.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We studied the presence of beta-lactamases with an extended spectrum of activity in clinical Escherichia coli isolates from Cairo, Egypt. Forty-six E. coli isolates were collected from patients with urinary tract infections at a University hospital in 2001. Phenotypic characterisation identified a very high extended-spectrum beta-lactamase (ESBL) rate of 60.9%. Pulsed-field gel electrophoresis and plasmid profiles revealed eight different clonal groups. All ESBL producers were polymerase chain reaction-positive for bla(TEM) and bla(CTX-M) genes. Within the CTX-M family, three different enzymes, CTX-M-14, CTX-M-15 and CTX-M-27, were found. The ESBL producers carried multiple plasmids and further plasmid-encoded resistances. In several strains, genes for up to six aminoglycoside-modifying enzymes were detected. A linkage to fluoroquinolone resistance was not observed. This study confirms the high rate of ESBLs in Egypt and further demonstrates the worldwide spread of genes coding for CTX-M enzymes in clinical isolates. (c) 2006 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:545 / 548
页数:4
相关论文
共 10 条
[1]   Effect of D240G substitution in a novel ESBL CTX-M-27 [J].
Bonnet, R ;
Recule, C ;
Baraduc, R ;
Chanal, C ;
Sirot, D ;
De Champs, C ;
Sirot, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) :29-35
[2]   Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries:: the PEARLS study 2001-2002 [J].
Bouchillon, SK ;
Johnson, BM ;
Hoban, DJ ;
Johnson, JL ;
Dowzicky, MJ ;
Wu, DH ;
Visalli, MA ;
Bradford, PA .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (02) :119-124
[3]  
BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P211
[4]   Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals [J].
El Kholy, A ;
Baseem, H ;
Hall, GS ;
Procop, GW ;
Longworth, DL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) :625-630
[6]   RAPID AND EFFICIENT COSMID CLONING [J].
ISHHOROWICZ, D ;
BURKE, JF .
NUCLEIC ACIDS RESEARCH, 1981, 9 (13) :2989-2998
[7]   BETA-LACTAMASES IN LABORATORY AND CLINICAL RESISTANCE [J].
LIVERMORE, DM .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :557-&
[8]   CTX-M: changing the face of ESBLs in the UK [J].
Livermore, DM ;
Hawkey, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (03) :451-454
[9]   Countrywide spread of community- and hospital-acquired extended-spectrum β-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon [J].
Moubareck, C ;
Daoud, Z ;
Hakimé, NI ;
Hamzé, M ;
Mangeney, N ;
Matta, H ;
Mokhbat, JE ;
Rohban, R ;
Sarkis, DK ;
Doucet-Populaire, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (07) :3309-3313
[10]   Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community [J].
Pitout, JDD ;
Nordmann, P ;
Laupland, KB ;
Poirel, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :52-59